Comment on Detection of Mycotoxins in Patients with Chronic Fatigue Syndrome. Toxins 2013, 5, 605–617
Conflicts of Interest
Reference
- Brewer, J.H.; Thrasher, J.D.; Straus, D.C.; Madison, R.A.; Hooper, D. Detection of mycotoxins in patients with chronic fatigue syndrome. Toxins 2013, 5, 605–617. [Google Scholar] [CrossRef]
© 2016 by the author; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Osterman, J.W. Comment on Detection of Mycotoxins in Patients with Chronic Fatigue Syndrome. Toxins 2013, 5, 605–617. Toxins 2016, 8, 322. https://doi.org/10.3390/toxins8110322
Osterman JW. Comment on Detection of Mycotoxins in Patients with Chronic Fatigue Syndrome. Toxins 2013, 5, 605–617. Toxins. 2016; 8(11):322. https://doi.org/10.3390/toxins8110322
Chicago/Turabian StyleOsterman, John W. 2016. "Comment on Detection of Mycotoxins in Patients with Chronic Fatigue Syndrome. Toxins 2013, 5, 605–617" Toxins 8, no. 11: 322. https://doi.org/10.3390/toxins8110322
APA StyleOsterman, J. W. (2016). Comment on Detection of Mycotoxins in Patients with Chronic Fatigue Syndrome. Toxins 2013, 5, 605–617. Toxins, 8(11), 322. https://doi.org/10.3390/toxins8110322